Dacarbazine Market Size, Share and Growth Analysis 2034
Dacarbazine, also referred to by its acronym DTIC, is a chemotherapeutic drug that is mostly used to treat certain cancers, such as Hodgkin's lymphoma and metastatic malignant melanoma. It belongs to the triazine family and is categorized as an alkylating agent. It works against cancer by damaging DNA in cancer cells, which prevents them from replicating and repairing themselves, which...
0 Commentarios
0 Acciones